BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Income Statement
Earnings Waterfall
BioCryst Pharmaceuticals Inc
Revenue
|
331.4m
USD
|
Cost of Revenue
|
-4.7m
USD
|
Gross Profit
|
326.8m
USD
|
Operating Expenses
|
-428.9m
USD
|
Operating Income
|
-102.2m
USD
|
Other Expenses
|
-124.4m
USD
|
Net Income
|
-226.5m
USD
|
Income Statement
BioCryst Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
17
N/A
|
17
-1%
|
18
+4%
|
19
+5%
|
14
-27%
|
17
+25%
|
41
+143%
|
49
+19%
|
48
-2%
|
46
-4%
|
25
-46%
|
22
-13%
|
26
+20%
|
31
+17%
|
29
-5%
|
30
+3%
|
25
-17%
|
20
-22%
|
29
+48%
|
22
-25%
|
21
-5%
|
23
+9%
|
12
-49%
|
12
+3%
|
49
+312%
|
48
-2%
|
49
+3%
|
54
+9%
|
18
-67%
|
32
+80%
|
79
+147%
|
114
+44%
|
157
+38%
|
188
+20%
|
204
+8%
|
238
+17%
|
271
+14%
|
290
+7%
|
307
+6%
|
318
+4%
|
331
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(3)
|
(3)
|
(3)
|
(4)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(4)
|
(3)
|
(3)
|
(4)
|
(2)
|
(8)
|
(8)
|
(7)
|
(7)
|
(2)
|
(2)
|
(5)
|
(7)
|
(7)
|
(8)
|
(6)
|
(5)
|
|
Gross Profit |
17
N/A
|
17
-1%
|
18
+4%
|
19
+5%
|
14
-28%
|
17
+25%
|
41
+142%
|
47
+16%
|
46
-2%
|
44
-4%
|
24
-47%
|
22
-9%
|
24
+9%
|
28
+18%
|
26
-6%
|
26
0%
|
24
-10%
|
18
-23%
|
27
+50%
|
21
-22%
|
20
-5%
|
21
+3%
|
10
-52%
|
10
+3%
|
45
+337%
|
45
+1%
|
47
+3%
|
49
+6%
|
16
-67%
|
25
+53%
|
71
+190%
|
107
+50%
|
150
+40%
|
186
+24%
|
202
+8%
|
234
+16%
|
264
+13%
|
282
+7%
|
299
+6%
|
312
+4%
|
327
+5%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(48)
|
(50)
|
(50)
|
(56)
|
(59)
|
(70)
|
(77)
|
(85)
|
(86)
|
(88)
|
(85)
|
(79)
|
(72)
|
(68)
|
(70)
|
(74)
|
(81)
|
(82)
|
(88)
|
(93)
|
(99)
|
(122)
|
(128)
|
(135)
|
(144)
|
(156)
|
(161)
|
(172)
|
(191)
|
(212)
|
(250)
|
(287)
|
(328)
|
(307)
|
(328)
|
(332)
|
(413)
|
(409)
|
(412)
|
(419)
|
(429)
|
|
Selling, General & Administrative |
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(10)
|
(11)
|
(12)
|
(13)
|
(12)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(14)
|
(14)
|
(14)
|
(14)
|
(14)
|
(17)
|
(23)
|
(31)
|
(37)
|
(47)
|
(52)
|
(57)
|
(68)
|
(74)
|
(87)
|
(104)
|
(119)
|
(131)
|
(143)
|
(145)
|
(159)
|
(173)
|
(186)
|
(200)
|
(214)
|
|
Research & Development |
(42)
|
(44)
|
(43)
|
(48)
|
(52)
|
(60)
|
(65)
|
(72)
|
(73)
|
(76)
|
(74)
|
(68)
|
(61)
|
(57)
|
(59)
|
(62)
|
(67)
|
(69)
|
(74)
|
(78)
|
(85)
|
(94)
|
(101)
|
(104)
|
(107)
|
(109)
|
(109)
|
(114)
|
(123)
|
(136)
|
(161)
|
(181)
|
(209)
|
(232)
|
(241)
|
(244)
|
(253)
|
(236)
|
(226)
|
(220)
|
(215)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(2)
|
0
|
56
|
56
|
56
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(31)
N/A
|
(33)
-7%
|
(32)
+2%
|
(37)
-15%
|
(46)
-24%
|
(53)
-15%
|
(36)
+32%
|
(37)
-4%
|
(39)
-5%
|
(44)
-12%
|
(62)
-40%
|
(58)
+6%
|
(49)
+16%
|
(40)
+17%
|
(44)
-8%
|
(48)
-9%
|
(57)
-20%
|
(64)
-12%
|
(60)
+6%
|
(71)
-18%
|
(78)
-10%
|
(101)
-29%
|
(118)
-16%
|
(125)
-6%
|
(100)
+20%
|
(111)
-12%
|
(115)
-3%
|
(122)
-7%
|
(175)
-43%
|
(187)
-7%
|
(178)
+5%
|
(180)
-1%
|
(178)
+1%
|
(120)
+32%
|
(126)
-4%
|
(98)
+22%
|
(148)
-51%
|
(127)
+14%
|
(113)
+11%
|
(107)
+5%
|
(102)
+5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
1
|
(3)
|
(6)
|
(2)
|
1
|
3
|
5
|
1
|
(4)
|
(7)
|
(10)
|
(11)
|
(7)
|
(6)
|
(4)
|
(3)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(5)
|
(8)
|
(9)
|
(9)
|
(4)
|
(2)
|
(2)
|
(6)
|
(22)
|
(36)
|
(47)
|
(60)
|
(71)
|
(81)
|
(90)
|
(96)
|
(96)
|
(98)
|
(98)
|
(94)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(11)
|
(16)
|
(16)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
56
|
0
|
0
|
0
|
0
|
0
|
(29)
|
(29)
|
(31)
|
|
Pre-Tax Income |
(30)
N/A
|
(36)
-19%
|
(38)
-7%
|
(39)
-2%
|
(45)
-16%
|
(50)
-11%
|
(31)
+39%
|
(37)
-19%
|
(43)
-18%
|
(51)
-18%
|
(72)
-42%
|
(69)
+4%
|
(55)
+20%
|
(47)
+16%
|
(47)
-1%
|
(51)
-8%
|
(66)
-30%
|
(77)
-18%
|
(79)
-2%
|
(93)
-18%
|
(101)
-8%
|
(107)
-5%
|
(126)
-18%
|
(134)
-6%
|
(109)
+19%
|
(115)
-6%
|
(116)
-1%
|
(125)
-7%
|
(183)
-46%
|
(210)
-15%
|
(214)
-2%
|
(227)
-6%
|
(182)
+20%
|
(191)
-5%
|
(206)
-8%
|
(188)
+9%
|
(244)
-30%
|
(223)
+9%
|
(240)
-7%
|
(235)
+2%
|
(226)
+4%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(3)
|
(5)
|
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
|
Income from Continuing Operations |
(30)
|
(36)
|
(38)
|
(39)
|
(45)
|
(50)
|
(31)
|
(37)
|
(43)
|
(51)
|
(72)
|
(69)
|
(55)
|
(47)
|
(47)
|
(51)
|
(66)
|
(77)
|
(79)
|
(93)
|
(101)
|
(107)
|
(126)
|
(134)
|
(109)
|
(115)
|
(116)
|
(125)
|
(183)
|
(210)
|
(214)
|
(227)
|
(184)
|
(194)
|
(210)
|
(193)
|
(247)
|
(226)
|
(243)
|
(236)
|
(227)
|
|
Net Income (Common) |
(30)
N/A
|
(36)
-19%
|
(38)
-7%
|
(39)
-2%
|
(45)
-16%
|
(50)
-11%
|
(31)
+39%
|
(37)
-19%
|
(43)
-18%
|
(51)
-18%
|
(72)
-42%
|
(69)
+4%
|
(55)
+20%
|
(47)
+16%
|
(47)
-1%
|
(51)
-8%
|
(66)
-30%
|
(77)
-18%
|
(79)
-2%
|
(93)
-18%
|
(101)
-8%
|
(107)
-5%
|
(126)
-18%
|
(134)
-6%
|
(109)
+19%
|
(115)
-6%
|
(116)
-1%
|
(125)
-7%
|
(183)
-46%
|
(210)
-15%
|
(214)
-2%
|
(227)
-6%
|
(184)
+19%
|
(194)
-5%
|
(210)
-8%
|
(193)
+8%
|
(247)
-28%
|
(226)
+8%
|
(243)
-7%
|
(236)
+3%
|
(227)
+4%
|
|
EPS (Diluted) |
-0.5
N/A
|
-0.59
-18%
|
-0.6
-2%
|
-0.54
+10%
|
-0.68
-26%
|
-0.69
-1%
|
-0.39
+43%
|
-0.51
-31%
|
-0.59
-16%
|
-0.7
-19%
|
-0.98
-40%
|
-0.94
+4%
|
-0.75
+20%
|
-0.63
+16%
|
-0.58
+8%
|
-0.6
-3%
|
-0.78
-30%
|
-0.78
N/A
|
-0.79
-1%
|
-0.88
-11%
|
-0.98
-11%
|
-0.96
+2%
|
-1.15
-20%
|
-1.21
-5%
|
-0.94
+22%
|
-0.74
+21%
|
-0.72
+3%
|
-0.7
+3%
|
-1.09
-56%
|
-1.2
-10%
|
-1.2
N/A
|
-1.27
-6%
|
-1.03
+19%
|
-1.04
-1%
|
-1.12
-8%
|
-1.05
+6%
|
-1.33
-27%
|
-1.21
+9%
|
-1.29
-7%
|
-1.25
+3%
|
-1.18
+6%
|